JournalsHub
.online
Find My Journal
JB

Jacqueline Benedetti

Duke University US

157
Publications
17,771
Citations
54
H-Index
90
i10-Index
3.0
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

Oxaliplatin (OXP) plus protracted infusion 5-fluorouracil (PIFU) and external beam radiation (EBRT) prior to surgery (S) for potentially curable esophageal adenocarcinoma (EA): A Southwest Oncology Group (SWOG) phase II trial with molecular correlates (S0356).

L. Leichman, B. Goldman, J. Benedetti, K. Billingsley, C. Thomas - Journal of Clinical Oncology, 2016
Cited by 9 Semantic Scholar

Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation OA

P. Bohanes, C. Rankin, C. Blanke, T. Winder, C. Ulrich - Clinical Cancer Research, 2015
Cited by 10 Semantic Scholar

Dual blockade of epidermal growth factor receptor and insulin‐like growth factor receptor–1 signaling in metastatic pancreatic cancer: Phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib (SWOG S0727) OA

P. Philip, B. Goldman, R. Ramanathan, H. Lenz, A. Lowy - Cancer, 2014
Cited by 87 Semantic Scholar

Issue information

P. Philip, B. Goldman, R. Ramanathan, H. Lenz, A. Lowy - Unknown Venue, 2014
Cited by 0 Semantic Scholar

Polymorphisms in folate‐metabolizing enzymes and response to 5‐fluorouracil among patients with stage II or III rectal cancer (INT‐0144; SWOG 9304) OA

C. Ulrich, C. Rankin, A. Toriola, K. Makar, Özge Altug-Teber - Cancer, 2014
Cited by 14 Semantic Scholar

Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial. OA

M. Gordon, H. Gundacker, J. Benedetti, J. Macdonald, J. Baranda - Annals of Oncology, 2013
Cited by 70 Semantic Scholar

SWOG S1115: Randomized phase II clinical trial of selumetinib (AZD6244; ARRY 142886) hydrogen sulfate (NSC-748727) and MK-2206 (NSC-749607) versus mFOLFOX in patients withmetastatic pancreatic cancer after prior chemotherapy.

V. Chung, Shannon L. McDonough, P. Philip, D. Cardin, A. Lowy - Unknown Venue, 2013
Cited by 5 Semantic Scholar

Assessment of HER 2 gene ampli fi cation in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116 / SWOG 9008 clinical trial

M. Gordon, H. Gundacker, J. Benedetti, J. Macdonald, J. Baranda - Unknown Venue, 2013
Cited by 6 Semantic Scholar

Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis. OA

K. Oba, X. Paoletti, S. Alberts, Y. Bang, J. Benedetti - Journal of the National Cancer Institute, 2013
Cited by 158 Semantic Scholar

Comparison of outcomes after fluorouracil-based adjuvant therapy for stages II and III colon cancer between 1978 to 1995 and 1996 to 2007: evidence of stage migration from the ACCENT database. OA

Q. Shi, T. André, A. Grothey, G. Yothers, S. Hamilton - Journal of Clinical Oncology, 2013
Cited by 74 Semantic Scholar

Research Topics

Colorectal Cancer Treatments and Studies (41) Herpesvirus Infections and Treatments (28) Gastric Cancer Management and Outcomes (27) Colorectal Cancer Surgical Treatments (16) Genetic factors in colorectal cancer (16)

Affiliations

University of Siena
IT 2004 - 2004
Ontario Institute for Cancer Research
CA 2009 - 2009
University of North Carolina at Chapel Hill
US 2007 - 2005
University of Southern California
US 2009 - 2007
Atrium Health Wake Forest Baptist
US 2007 - 2007

External Profiles

OpenAlex Profile Semantic Scholar Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now